ethnopharmacolog
relev
radic
glycyrrhiza
uralensi
fisch
herbal
prepar
contain
glycyrrhiza
spp
use
thousand
year
herbal
medicin
treatment
viral
induc
cough
viral
hepat
viral
skin
diseas
like
ulcer
china
glycyrrhiz
acid
ga
consid
princip
compon
glycyrrhiza
spp
wide
spectrum
antivir
activ
aim
present
studi
attempt
valid
medicin
use
glycyrrhiza
uralensi
hand
foot
mouth
diseas
hfmd
verifi
whether
ga
activ
antivir
compon
water
extract
glycyrrhiza
uralensi
materi
method
radic
glycyrrhiza
uralensi
fisch
extract
hot
water
chemic
content
extract
profil
hplc
analysi
antivir
activ
extract
major
compon
evalu
infect
enteroviru
coxsackieviru
vero
cell
cytopath
effect
caus
infect
measur
mtt
assay
infecti
virion
product
determin
use
secondari
infect
assay
viral
protein
express
immunoblot
analysi
extract
mgml
suppress
replic
log
log
antivir
activ
associ
content
ga
extract
sinc
select
deplet
ga
extract
acid
precipit
result
loss
antivir
activ
contrast
acid
precipit
retain
antivir
activ
precipit
concentr
mgml
inhibit
replic
log
respect
furthermor
ga
dosedepend
block
viral
replic
mm
ga
reduc
infecti
product
log
respect
mm
product
reduc
log
log
member
enteroviru
genu
timeofdrug
addit
studi
howev
show
ga
directli
inactiv
ga
effect
associ
event
post
viru
cell
entri
conclus
studi
valid
medicin
use
radic
glycyrrhiza
uralensi
etiolog
agent
hfmd
addit
identif
ga
antivir
compon
glycyrrhiza
uralensi
infect
studi
also
reveal
ga
inhibit
distinct
mechan
glycyrrhiz
acid
antivir
compon
glycyrrhiza
uralensi
fisch
coxsackieviru
enteroviru
hand
foot
mouth
diseas
hand
foot
mouth
diseas
hfmd
common
viral
ill
usual
affect
infant
young
children
year
old
younger
clinic
featur
hfmd
typic
begin
mild
fever
sore
throat
poor
appetit
diarrhea
day
two
later
blister
form
mouth
rash
develop
cheek
gum
tongu
potenti
lifethreaten
neurolog
complic
enceph
caus
agent
hfmd
identifi
coxsackieviru
enteroviru
virus
account
case
outbreak
china
singl
strand
rna
virus
enteroviru
genu
virus
spread
direct
contact
blister
surfac
contamin
viruscontain
fluid
fecalor
rout
hfmd
occur
sporad
around
world
sinc
first
report
larg
outbreak
hfmd
higher
morbid
mortal
becom
common
asia
pacif
region
outbreak
affect
nearli
half
million
children
death
eastern
china
yang
et
al
data
report
ministri
public
health
china
show
one
million
case
annual
hundr
death
associ
hfmd
china
past
year
wwwmohgovcn
vaccin
specif
antivir
drug
avail
hfmd
good
hygien
includ
hand
wash
disinfect
surfac
child
care
facil
therefor
remain
effect
approach
reduc
transmiss
rate
hfmd
solomon
et
al
et
al
radic
glycyrrhiza
spp
commonli
known
gan
cao
chines
licoric
english
use
thousand
year
herbal
medicin
treatment
sore
throat
cough
bronchiti
peptic
ulcer
da
et
al
krauss
et
al
arthriti
allerg
diseas
fior
et
al
asl
hosseinzadeh
kim
et
al
plant
extract
also
use
flavor
agent
food
beverag
rel
safe
profil
outbreak
hfmd
china
medicin
herb
herbal
prepar
demonstr
therapeut
efficaci
amelior
symptom
diseas
andor
shorten
cours
diseas
herb
report
therapeut
effect
use
tradit
folklor
inflammatori
andor
infect
diseas
xue
et
al
cao
et
al
glycyrrhiza
spp
report
broad
antivir
activ
fior
et
al
glycyrrhiz
acid
ga
also
known
glycyrrhizin
glycyrrhizin
acid
major
bioactiv
compon
glycyrrhiza
spp
demonstr
activ
dna
rna
virus
ga
millimolar
concentr
inhibit
growth
cytopatholog
sever
unrel
virus
affect
cell
activ
abil
replic
pompei
et
al
subsequ
studi
shown
antivir
activ
ga
sever
envelop
virus
includ
hiv
sar
relat
coronaviru
cinatl
et
al
hoever
et
al
kaposi
sarcomaassoci
herpesviru
curr
et
al
kang
lieberman
hepat
c
viru
ashfaq
et
al
respiratori
syncyti
viru
vaccinia
viru
epsteinbarr
viru
vesicular
stomat
viru
fior
et
al
fior
et
al
pompei
et
al
compound
previous
report
inhibit
infect
nonenvelop
virus
plant
like
glycyrrhiza
uralensi
houttuynia
cordata
demonstr
strong
antivir
activ
infect
kuo
et
al
lin
et
al
howev
antivir
activ
infect
activ
compon
herb
still
undetermin
studi
aim
assess
infect
activ
water
extract
glycyrrhiza
uralensi
determin
whether
antivir
activ
glycyrrhiza
uralensi
attribut
ga
antibodi
protein
purchas
abnova
taiwan
human
gapdh
bioworld
technolog
minneapoli
mn
hors
radish
peroxidas
hrp
conjug
secondari
antibodi
sigma
st
loi
mo
chemic
includ
acyclovir
acv
acid
bga
ammonium
glycyrrhiz
methyl
thiazolyl
diphenyltetrazolium
bromid
mtt
purchas
sigmaaldrich
st
loui
mo
liquiritin
chengdu
biopurifi
pharmaceut
chengdu
chemiluminesc
ecl
reagent
kit
enhanc
detect
sensit
purchas
thermo
fisher
pittsburgh
pa
african
green
monkey
kidney
vero
cell
purchas
cell
bank
chines
academi
scienc
shanghai
china
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fetal
bovin
serum
fb
invitrogen
uml
penicillin
streptomycin
mm
lglutamin
kindli
provid
dr
c
zheng
wuhan
univers
clinic
isol
subgenotyp
sequenc
analysi
zhang
et
al
virus
propag
vero
cell
viru
titer
determin
vero
cell
measur
tissu
cultur
infect
dose
tcid
plaqu
form
assay
slice
radic
glycyrrhiza
uralensi
fisch
purchas
local
drug
store
nanj
identifi
ms
yunxia
xu
research
assist
nanj
univers
hplc
profil
follow
instruct
chines
pharmacopeia
fig
voucher
specimen
store
laboratori
microbi
scienc
pharmaci
school
medicin
nanj
univers
materi
ground
extract
boil
water
describ
kuo
et
al
adjust
ph
liquid
dilut
naoh
liquid
filter
test
antivir
activ
lyophil
futur
studi
lyophil
powder
store
reconstitut
deioniz
water
dih
prior
experi
deplet
ga
ph
extract
adjust
ph
h
precipit
ga
overnight
precipit
supernat
collect
filtrat
precipit
rins
cold
water
two
time
lyophil
addit
supernat
also
lyophil
adjust
ph
dilut
naoh
precipit
supernat
reconstitut
dih
prior
experi
acid
precipit
concentr
glycyrrhiz
acid
water
extract
effect
lu
et
al
standard
procedur
recommend
us
food
drug
administr
cfr
titl
sec
licoric
licoric
deriv
ident
water
extract
character
hplc
profil
glycyrrhiz
acid
liquiritin
specifi
chines
pharmacopeia
boschroma
odsaq
column
mm
mm
particl
size
acetonitrileh
contain
trifluoroacet
acid
mobil
phase
use
compon
monitor
nm
uv
detector
ammonium
glycyrrhiz
liquiritin
use
standard
hplc
studi
vero
cell
triplic
duplic
infect
viru
multipl
infect
moi
test
inhibitori
effect
compound
stock
solut
test
sampl
pb
dmso
solvent
control
dmso
ad
vero
cell
h
infect
compound
left
medium
throughout
infect
assay
cytopath
effect
caus
viru
infect
quantit
measur
use
mtt
assay
mosmann
approxim
h
postinfect
pi
inhibit
rate
calcul
percentag
od
treat
od
infect
od
uninfect
od
infect
altern
cell
fix
paraformaldehyd
stain
crystal
violet
prior
photograph
digit
camera
secondari
infect
assay
vero
cell
pretreat
without
extract
ga
h
infect
moi
cell
cultur
supernat
collect
h
pi
freezethaw
liquid
nitrogen
releas
infecti
viru
seriesdilut
supernat
test
vero
cell
describ
liu
et
al
tcid
number
calcul
use
method
reed
muench
plaqu
form
unit
pfu
number
calcul
enumer
sampl
plaqu
timeofdrug
addit
experi
vero
cell
infect
moi
ga
mm
ad
h
prior
infect
infect
vari
time
post
infect
ga
left
medium
throughout
infect
assay
cytopath
effect
determin
measur
cell
viabil
use
mtt
assay
h
pi
virucid
activ
assay
carri
determin
whether
ga
directli
inactiv
virus
resuspend
ml
cultur
medium
treat
ga
mm
water
bath
min
aliquot
ml
treat
viru
use
infect
vero
cell
moi
final
concentr
ga
mm
sampl
harvest
h
pi
titrat
infecti
virus
secondari
infect
assay
vero
cell
infect
moi
h
presenc
absenc
ga
cell
lyse
lysi
buffer
contain
mm
nacl
mm
trishcl
ph
cocktail
proteas
inhibitor
roch
cell
lysat
subject
separ
sdspage
protein
transfer
pvdf
membran
millipor
sampl
detect
incub
antibodi
protein
follow
hrpconjug
secondari
antibodi
ecl
reagent
kit
gapdh
use
load
control
imag
captur
use
alpha
innotech
flour
imag
system
san
leandro
ca
maximum
noncytotox
concentr
test
compound
determin
vero
cell
incub
vero
cell
test
compound
vari
concentr
h
maximum
noncytotox
concentr
defin
signific
reduct
cell
viabil
determin
mtt
assay
investig
antivir
effect
glycyrrhiza
uralensi
water
extract
glycyrrhiza
uralensi
prepar
test
antivir
activ
infect
cell
cultur
system
qualiti
extract
valid
hplc
analysi
fig
content
ga
liquiritin
extract
use
antivir
studi
determin
exceed
specifi
amount
chines
pharmacopeia
test
antivir
activ
found
extract
mgml
mgml
significantli
block
cytopath
effect
caus
infect
mgml
extract
block
infect
respect
fig
effect
extract
less
potent
becam
signific
mgml
addit
antivir
activ
verifi
secondari
infect
assay
titrat
infecti
virion
product
sampl
treat
mgml
extract
log
less
infecti
virion
sampl
detect
fig
c
indic
water
extract
glycyrrhiza
uralensi
possess
antivir
activ
water
extract
devoid
antivir
activ
deplet
ga
acid
precipit
therefor
focus
attent
identif
antivir
compon
water
extract
glycyrrhiza
uralensi
chemic
compon
glycyrrhiza
spp
well
investig
rel
clear
plant
genu
contain
triterpenoid
saponin
glycyrrhiz
acid
dihydroflavonoid
like
liquiritin
polysaccharid
asl
hosseinzadeh
ga
princip
compon
antivir
activ
ga
three
carboxyl
acid
group
select
precipit
acidif
aqueou
solut
preliminarili
determin
whether
ga
respons
glycyrrhiza
uralensi
antivir
activ
precipit
ga
water
extract
glycyrrhiza
uralensi
h
detect
antivir
activ
precipit
supernat
consist
ga
antivir
compon
deplet
ga
acid
precipit
obviat
antivir
activ
extract
fig
b
expect
acid
precipit
ga
content
significantli
enrich
show
strong
antivir
activ
mgml
precipit
block
infecti
product
log
respect
suggest
ga
primari
antivir
compon
glycyrrhiza
uralensi
confirm
whether
ga
activ
compon
glycyrrhiza
uralensi
infect
first
determin
maximum
nontox
concentr
ga
vero
cell
mm
antivir
studi
show
treatment
ga
mm
concentr
notic
suppress
cytopath
effect
associ
infect
h
fig
inhibit
ga
infect
valid
use
secondari
infect
assay
shown
fig
c
compar
untreat
control
treatment
ga
mm
result
reduc
product
log
respect
fig
concentr
product
reduc
approxim
log
respect
fig
contrast
acid
bga
liquiritin
compon
glycyrrhiza
uralensi
maximum
nontox
concentr
mm
bga
mm
liquiritin
respect
show
antivir
effect
data
shown
inhibit
infect
ga
also
confirm
immunoblot
assay
protein
product
shown
fig
ga
mm
block
protein
express
cell
fix
paraformaldehyd
h
pi
stain
crystal
violet
inhibit
infect
prevent
cell
death
henc
increas
stain
compar
infect
untreat
control
result
repres
two
independ
experi
b
c
glycyrrhiz
acid
treatment
reduc
infecti
virion
product
assay
inhibit
virion
product
vero
cell
treat
glycyrrhiz
acid
mm
remain
untreat
cell
infect
b
c
moi
sampl
harvest
h
pi
infecti
virion
sampl
assay
secondari
infect
assay
data
present
mean
error
triplic
sampl
three
independ
experi
glycyrrhiz
acid
treatment
inhibit
protein
express
vero
cell
infect
presenc
absenc
glycyrrhiz
acid
concentr
indic
cell
harvest
h
pi
express
sampl
detect
immunoblot
analysi
gapdh
use
load
control
result
repres
two
independ
experi
result
togeth
demonstr
ga
function
activ
compon
glycyrrhiza
uralensi
antivir
activ
infect
investig
mechan
ga
inhibit
infect
perform
timeofdrug
addit
experi
determin
stage
ga
inhibit
infect
shown
fig
pretreat
addit
ga
within
first
min
later
stage
infect
significantli
reduc
caus
cytopath
effect
vero
cell
indic
ga
potenti
deactiv
viru
inhibit
infect
target
earli
event
infect
contrast
pretreat
host
cell
treatment
within
first
h
pi
block
infect
compar
level
suggest
ga
inhibit
infect
target
event
post
cell
entri
demonstr
ga
inactiv
directli
perform
virucid
activ
assay
shown
fig
c
coincub
ga
significantli
reduc
infect
treatment
show
effect
infect
demonstr
ga
block
infect
like
direct
inactiv
viru
kuo
et
al
recent
report
water
extract
radic
glycyrrhiza
uralensi
fisch
possess
strong
antivir
activ
infect
ic
valu
determin
mgml
howev
compon
potent
antivir
activ
remain
uncharacter
studi
detect
moder
antivir
activ
extract
infect
demonstr
ga
contribut
antivir
activ
glycyrrhiza
uralensi
addit
ga
signatur
compon
glycyrrhiza
spp
chines
pharmacopeia
specifi
minim
content
report
ga
content
glycyrrhiza
uralensi
fisch
differ
cultiv
area
vari
significantli
gu
et
al
consist
report
found
content
ga
five
sampl
purchas
local
market
vari
dramat
data
shown
therefor
specul
differ
ga
content
cell
line
may
contribut
discrep
report
activ
glycyrrhiza
spp
compar
studi
use
glycyrrhiza
speci
symptom
viral
respiratori
tract
infect
trace
back
ancient
chines
indian
greek
manuscript
fior
et
al
fior
et
al
pompei
et
al
report
repres
first
case
ga
antivir
activ
nonenvelop
virus
timeofdrug
addit
studi
reveal
ga
inhibit
infect
differ
mechan
compound
directli
inactiv
inhibit
infect
appar
event
post
cell
entri
viru
glycyrrhiz
acid
exhibit
antivir
activ
multipl
mechan
includ
direct
deactiv
pompei
et
al
reduct
host
cell
membran
fluiditi
harada
inhibit
fusion
envelop
virus
wolkerstorf
et
al
impair
hepat
b
viru
surfac
antigen
transport
sato
et
al
disrupt
rna
polymeras
ii
paus
result
loss
proper
mrna
product
defect
sister
chromatid
cohes
kang
lieberman
glycyrrhizin
inhibit
highli
pathogen
influenza
viru
infect
viru
replic
antioxid
effect
cell
micha
et
al
micha
et
al
mechan
ga
inhibit
infect
remain
unknown
worth
note
similar
report
concentr
ga
inhibit
viru
infect
found
concentr
requir
ga
inhibit
infect
also
millimolar
rang
anim
clinic
studi
seem
suggest
therapeut
effect
ga
accomplish
lower
concentr
doubleblind
random
placebocontrol
phase
iii
trial
chronic
hepat
c
intraven
deliveri
glycyrrhizin
mg
thrice
weekli
lower
serum
alanin
aminotransferas
alt
treatment
effect
hcvrna
level
detect
van
rossum
et
al
whether
drug
metabol
process
factor
play
role
ga
activ
unknown
physiolog
protein
lampi
et
al
biolog
lipid
lampi
et
al
known
enhanc
ga
activ
transmit
close
contact
blister
surfac
contamin
nose
throat
discharg
infect
person
via
fecalor
rout
glycyrrhiz
acid
food
addit
consid
safe
consum
high
dose
recent
assess
safeti
ga
salt
cosmet
ingredi
review
expert
panel
state
compound
expect
poorli
absorb
skin
andersen
ingredi
consid
irrit
sensit
phototox
agent
photosensit
current
maximum
concentr
use
therefor
identif
ga
antivir
activ
hfmd
pathogen
may
lead
develop
hygien
product
